Adeka (4401) Q4 2025 earnings summary

Executive summary

• FY2024 net sales, operating profit, ordinary profit, and profit attributable to owners of parent reached record highs; net sales were ¥407,145 million and operating profit ¥41,010 million.

• Chemicals led growth; Food Products and Life Science sales declined while operating profit increased.

Financial highlights

• Net sales rose 1.8% to ¥407,145 million; operating profit increased 15.8% to ¥41,010 million and ordinary profit rose 10.0% to ¥39,346 million.

• Profit attributable to owners of parent increased 8.9% to ¥25,019 million; basic earnings per share rose to ¥245.55 from ¥224.87.

• Operating profit margin improved to 10.1% from 8.9%; ROE rose to 8.6% from 7.2% and capital adequacy ratio to 54.6% from 52.5%.

• Cash and cash equivalents increased 11.2% to ¥107,768 million; interest-bearing debt fell ¥9.8 billion year over year.

Outlook and guidance

• FY2025 guidance: net sales ¥441 billion, operating profit ¥43 billion, ordinary profit ¥43 billion, and profit attributable to owners of parent ¥26.4 billion; all forecast to increase year over year.

• FY2025 net sales are forecast to increase across all segments; Semiconductor Materials and Life Science operating profit are expected to decline slightly.

• Polymer Additives and Environmental Materials expect higher sales and operating profit; Food Products expects higher sales and a slight profit increase.

• FY2025 EPS is projected at ¥259.5 and annual dividend at ¥104 per share; dividend payout ratio is expected to remain above 40%.